IPAB dismisses patent revocation against Kibow

The Intellectual Property Appellate Board (IPAB) has dismissed an application filed by La Renon Health Care Pvt Ltd against a patent granted to the US-based Kibow Biotech Inc., for a probiotic dietary supplement.

Kibow Biotech, in a press release, said the IPAB order was related to a granted product patent. The patent granted to Kibow Biotech Inc. is for the invention--"compositions for augmenting kidney function".

Rejecting on various grounds including obviousness, representation claims that the composition is a mere admixture , IPAB vice chairman S Usha and technical member (patents) DPS Parmar, ordered, "In view of the above analysis the revocation application stands to be dismissed".